Big Pharma smetterà di investire nel Regno Unito, avverte lo scienziato eminente Sir John Bell
https://www.theguardian.com/business/2025/sep/11/big-pharma-will-halt-investments-in-uk-warns-eminent-scientist-sir-john-bell
di printial
Big Pharma smetterà di investire nel Regno Unito, avverte lo scienziato eminente Sir John Bell
https://www.theguardian.com/business/2025/sep/11/big-pharma-will-halt-investments-in-uk-warns-eminent-scientist-sir-john-bell
di printial
10 commenti
Um, are they threatening us *or* threatening us with a good time?
What an utter load of shite.
Billions to be made and they’re going to stop? Keep the line moving idiot.
So to tl;dr… Can you please stop using the economies of scale of a universal public healthcare system to drive down drug prices so we can make more profit or we’ll throw our toys out the pram.
“Big Pharma” is fucking scourge on the planet anyway, taking government funded base research, and then using it only to line their profit margins as much as physically possible.
It would be vastly better for a country like the UK, with a nationalised health service to spend that money on continuing the promising university research through to it’s logical end – and then selling any resulting drugs to other markets to defray the cost of future development.
Small pharma will fill the void.
I really don’t understand when people threaten to leave, like when the millionaires threatened. Ok? you leave a void which will be filled
I always wondered what the feasibility is of the NHS having their own in house Pharmaceutical Company / Manufacturing capability is.
Considering the sheer size of the NHS would it be financially viable long term for this to be a thing.
The real problem with Pharma is probably the broken business model, although the way out could be expensive custom tailored gene therapies. Which are, again: EXPENSIVE. Not for UK and NHS. The other option is an growing infinite number of vaccines which governments must purchase.
Article: Pharma’s broken business model – Part 1: An industry on the brink of terminal decline
[https://www.linkedin.com/pulse/pharmas-broken-business-model-industry-brink-terminal-kelvin-stott/](https://www.linkedin.com/pulse/pharmas-broken-business-model-industry-brink-terminal-kelvin-stott/)
Don’t let the door hit ya scummy ass on the way out!
I’m going to point out that Big Pharma already has limited investment (as the article says, title seems a bit misleading), as we saw a few years ago with one company, and again yesterday with Merck. The life sciences sector has been saying for a while now we are in huge trouble, and the damage of Brexit / leaving Horizon in an age of globalization has absolutely hit hard. I believe there was some analysis back when that other company made their decision on location (can’t recall who it was now).
The fundamental issues of the business needing cashflow which comes from US prescriptions while Trump is threatening tariffs and price increases is also biting hard, as we saw with Eli Lilly and Monjaro price increase the other day. The US does effectively subsidize the rest of the world and is a huge market with strong patent controls.
NICE (and the NHS) have been fighting tooth and nail to get cheaper prices for a while, and the stats in the article seem to explain why talks broke down.
I have absolutely no idea how they will resolve this issue. It probably needs a report and a specialist committee looking at it so the government can identify some policies to tackle it. Considering investment will generate jobs and growth, that headline would certainly help Labour right now.
They already are and have been doing so since Brexit.